The first-in-human trial saw all three patients able to increase their walking distance within six minutes to 20 meters.

Still, Medtronic executives have said their new device, called Inceptiv, is a game changer that they expect to “revolutionize ...

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).

A new spinal cord implant may help people with spinal muscular atrophy (SMA) regain some muscle function, giving the ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

Axonics defeats Medtronic lawsuit in spine-stimulation patent trial Legalcategory· September 19, 2024 Medtronic slightly lifted the lower end of its annual profit forecast on Tuesday, banking on ...

Year-old SPR (it stands for “stimulation for pain relief”) is one of the newest ... sale of a urinary incontinence-treating product to Medtronic in 2008, has started NDI Healthcare Fund ...